5-Star Stocks Poised to Pop: Thermo Fisher Scientific


Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, analytical instrument specialist Thermo Fisher Scientific (NYS: TMO) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Thermo Fisher's business and see what CAPS investors are saying about the stock right now.

Thermo Fisher facts

Headquarters (founded)

Waltham, Mass. (1956)

Market Cap

$18.7 billion


Life sciences tools and services

Trailing-12-Month Revenue

$12.1 billion


CEO Marc Casper (since 2009)
CFO Peter Wilver (since 2004)

Return on Equity (average, past 3 years)



$792.6 million / $6.7 billion

Dividend Yield



Agilent Technologies
Beckman Coulter
Becton Dickinson

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 565 members who have rated Thermo Fisher believe the stock will outperform the S&P 500 going forward.

Just last month, one of those Fools, SotaiR, offered some insight into the Thermo Fisher bull case:

As an employee I can say things are good at Thermo Fisher Scientific. The roll out of Unity Lab Services has given the company a unique position in the asset management/services sector to add to their competitive catalog and their outstanding brands of instruments (Thermo) and lab supplies (Fisher). This new brand (Unity) will position them to corner the market even more. Keep your eyes on this stock, safe bet, great management and great people.

If you want market-topping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite a strong five-star rating, Thermo Fisher may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the newTrackPoisedToCAPS account.

At the time thisarticle was published Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Thermo Fisher Scientific and Becton. Try any of our Foolish newsletter services free for 30 days.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.